WallStSmart

Exponent Inc (EXPO)vsPACCAR Inc (PCAR)

VS

Smart Verdict

WallStSmart Research — data-driven comparison

PACCAR Inc generates 4940% more annual revenue ($27.78B vs $551.14M). EXPO leads profitability with a 19.8% profit margin vs 8.9%. PCAR appears more attractively valued with a PEG of 1.12. EXPO earns a higher WallStSmart Score of 62/100 (C+).

EXPO

Buy

62

out of 100

Grade: C+

Growth: 5.3Profit: 9.0Value: 5.3Quality: 8.0
Piotroski: 3/9Altman Z: 3.41

PCAR

Buy

56

out of 100

Grade: C

Growth: 4.0Profit: 6.0Value: 4.7Quality: 6.5
Piotroski: 1/9Altman Z: 2.09
IV

Intrinsic Value Comparison

Multi-model valuation · Graham Formula

EXPOUndervalued (+0.1%)

Margin of Safety

+0.1%

Fair Value

$71.76

Current Price

$59.66

$12.10 discount

UndervaluedFair: $71.76Overvalued
PCARSignificantly Overvalued (-37.6%)

Margin of Safety

-37.6%

Fair Value

$84.77

Current Price

$118.06

$33.30 premium

UndervaluedFair: $84.77Overvalued

Key Strengths & Concerns

Side-by-side fundamental analysis

Key Strengths

EXPO4 strengths · Avg: 9.3/10
Return on EquityProfitability
32.2%10/10

Every $100 of equity generates 32 in profit

Altman Z-ScoreHealth
3.4110/10

Safe zone — low bankruptcy risk

Debt/EquityHealth
0.249/10

Conservative balance sheet, low leverage

Operating MarginProfitability
27.3%8/10

Strong operational efficiency at 27.3%

PCAR1 strengths · Avg: 9.0/10
Market CapQuality
$59.41B9/10

Large-cap with strong market position

Areas to Watch

EXPO4 concerns · Avg: 3.8/10
PEG RatioValuation
2.034/10

Expensive relative to growth rate

P/E RatioValuation
26.7x4/10

Moderate valuation

Price/BookValuation
8.6x4/10

Trading at 8.6x book value

Piotroski F-ScoreQuality
3/93/10

Weak financial health signals

PCAR2 concerns · Avg: 2.5/10
Piotroski F-ScoreQuality
1/93/10

Weak financial health signals

Revenue GrowthGrowth
-8.9%2/10

Revenue declined 8.9%

Comparative Analysis Report

WallStSmart Research

Bull Case : EXPO

The strongest argument for EXPO centers on Return on Equity, Altman Z-Score, Debt/Equity. Profitability is solid with margins at 19.8% and operating margin at 27.3%. Revenue growth of 10.5% demonstrates continued momentum.

Bull Case : PCAR

The strongest argument for PCAR centers on Market Cap. PEG of 1.12 suggests the stock is reasonably priced for its growth.

Bear Case : EXPO

The primary concerns for EXPO are PEG Ratio, P/E Ratio, Price/Book.

Bear Case : PCAR

The primary concerns for PCAR are Piotroski F-Score, Revenue Growth.

Key Dynamics to Monitor

EXPO profiles as a mature stock while PCAR is a value play — different risk/reward profiles.

PCAR carries more volatility with a beta of 1.03 — expect wider price swings.

EXPO is growing revenue faster at 10.5% — sustainability is the question.

PCAR generates stronger free cash flow (825M), providing more financial flexibility.

Bottom Line

EXPO scores higher overall (62/100 vs 56/100), backed by strong 19.8% margins and 10.5% revenue growth. Both earn "Buy" and "Buy" ratings respectively — the choice depends on your investment horizon and risk tolerance.

This analysis is generated from publicly available financial data. Not financial advice.

Exponent Inc

INDUSTRIALS · ENGINEERING & CONSTRUCTION · USA

Exponent, Inc., is a global science and engineering consulting company. The company is headquartered in Menlo Park, California.

PACCAR Inc

INDUSTRIALS · FARM & HEAVY CONSTRUCTION MACHINERY · USA

PACCAR Inc is an American Fortune 500 company and counts among the largest manufacturers of medium- and heavy-duty trucks in the world. PACCAR is engaged in the design, manufacture and customer support of light-, medium- and heavy-duty trucks under the Kenworth, Peterbilt, Leyland Trucks, and DAF nameplates. PACCAR also designs and manufactures powertrains, provides financial services and information technology, and distributes truck parts related to its principal business.

Want to dig deeper into these stocks?